In This Issue of Psychiatric Times
Read the latest issue cover-to-cover, with a bonus PDF.


Pharma in the News: The Good and the Bad
Drug companies are investing more to study psychiatric disorders, and there may be novel treatments in the near future.
(Image: ©Brizmakers/AdobeStock)

More Mental Health Content from Psychiatric Times
 
Surprising Benefits of the Expansion of Coverage Under the Affordable Care Act
Differential Diagnosis of Posttraumatic Psychosis
Lifelong Learning—The Annual Psychiatric Times® World CME Conference™
Psychiatry Comic: Identity Crisis
Demographic Insights in Alcohol-Related Deaths